Quantitative risk reduction through peanut immunotherapy: Safety benefits of an increased threshold in Europe
Sign Up to like & getrecommendations! Published in 2018 at "Pediatric Allergy and Immunology"
DOI: 10.1111/pai.12961
Abstract: The clinical relevance of increasing an allergic individual's peanut sensitivity threshold by immunotherapy, that is, eliciting dose (ED) to 300 or 1000 mg peanut protein, has not been previously characterized in a European population. In… read more here.
Keywords: immunotherapy; risk reduction; increased threshold; quantitative risk ... See more keywords